History. Many of the therapeutic proposals for COVID-19 are already associated with adverse results, such as the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to ascertain the use of prescription drugs that has a risk of QT interval prolongation in 21 clinics/hospitals in https://directivepublications.org/journal-of-vascular-medicine/